GO:1902532 negative regulation of intracellular signal transduction: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902532 describes any process that stops, prevents, or reduces the frequency, rate, or extent of intracellular signal transduction, and it is annotated as a biological_process in the Gene Ontology.
• Negative regulation of intracellular signal transduction is essential for preventing runaway signaling, maintaining cellular homeostasis, and shaping the duration and amplitude of responses to cytokines, growth factors, and innate immune stimuli.
• Key molecular strategies include negative feedback loops, decoy receptors, inhibitory proteins, endocytic trafficking, and post-translational modification such as ubiquitination and SUMOylation.
• Dysregulation of these brakes is linked to autoinflammatory disease, cancer, and developmental disorders, making the pathway a rich source of therapeutic targets.
• CRISPR knockout, point-mutation, knock-in, and overexpression models allow researchers to dissect which components are causally required for negative regulation in a given cell type.
• EDITGENE provides end-to-end CRISPR cell model generation and CRISPR library screening / bioinformatics services to accelerate functional studies of negative regulators of intracellular signal transduction.
Description
Intracellular signal transduction is the process by which a cell converts an external or internal cue into a coordinated biochemical response. To avoid excessive or prolonged signaling, cells deploy dedicated negative regulators that stop, prevent, or reduce the frequency, rate, or extent of these signaling events. The Gene Ontology term GO:1902532, negative regulation of intracellular signal transduction, captures this essential braking function. Understanding this term is important because the same negative regulators that protect against autoimmunity and uncontrolled proliferation can also be hijacked by pathogens or tumors to evade immune surveillance. Researchers studying signaling dynamics, drug resistance, or inflammatory disease therefore need reliable tools to identify and manipulate these negative regulators.
negative regulation of intracellular signal transduction At A Glance
| GO ID | GO:1902532 |
|---|---|
| GO term | negative regulation of intracellular signal transduction |
| Ontology | biological_process |
| Synonym | inhibition of intracellular signal transduction; down-regulation of intracellular signaling cascade; negative regulation of intracellular signaling pathway |
| Major function | Stops, prevents, or reduces the frequency, rate, or extent of intracellular signal transduction |
| Biological context | Negative feedback, signal attenuation, and homeostatic control of cytokine, growth factor, and innate immune signaling |
| Representative regulators | TAX1BP1, TNIP1, PIAS1, SMAD7, ESCRT components, Gβγ subunits |
| Disease relevance | Autoinflammation, cancer, developmental disorders, and immune dysregulation |
| Research methods | CRISPR KO/point mutation/knock-in/overexpression, RNA-seq, proteomics, imaging, CRISPR library screening |
What Is GO:1902532?
GO:1902532 is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of intracellular signal transduction. In practice, this includes mechanisms such as inhibitory phosphorylation, ubiquitin-mediated degradation of signaling intermediates, sequestration of signaling molecules by decoy or scaffold proteins, and feedback loops that shut down a pathway after it has been activated. The term is a biological_process and is distinct from positive regulation of intracellular signal transduction, which promotes signaling.
Why Is negative regulation of intracellular signal transduction Important in Cell Biology?
Negative regulation of intracellular signal transduction is important because it sets the threshold, duration, and amplitude of cellular responses. Without these brakes, cells can suffer chronic inflammation, uncontrolled proliferation, or developmental defects. The process is also a major mechanism by which cells adapt to changing environments and avoid exhaustion of signaling components.
• Prevents runaway NF-κB and STING signaling that would otherwise cause autoinflammation.
• Controls the duration of TGF-β/Smad responses during development and tissue homeostasis.
• Regulates endocytic trafficking of receptors, which determines whether signaling is sustained or terminated.
• Modulates innate immune responses to pathogens and danger signals.
• Influences cancer cell survival by tuning pro-survival and pro-apoptotic signaling.
• Provides targets for anti-inflammatory and anti-tumor drug discovery.
• Helps explain resistance to targeted therapies that depend on sustained signaling.
• Is essential for normal pigmentation and hormonal responses in mammalian skin.
• Shapes G-protein-coupled receptor signaling through Gβγ subunit interactions.
• Offers a rich source of causal genes for functional genomics and CRISPR screening.
What Happens During negative regulation of intracellular signal transduction?
Initiation of negative feedback
In simple terms: When a signal is switched on, the cell also switches on brakes that will later shut it down.
Negative regulation often begins with the same stimulus that activates a pathway. For example, STING activation induces feedback factors such as TAX1BP1 and TNIP1 that later attenuate the response. Similarly, cytokine signaling induces inhibitory proteins like PIAS1 that limit NF-κB activity. This coupling ensures that the brake is engaged only when the pathway is active.
Recruitment of inhibitory complexes
In simple terms: Brake proteins are brought to the signaling machinery to stop it.
Inhibitory complexes are recruited to activated signaling intermediates. TAX1BP1 directs Golgiphagy to degrade STING and terminate signaling, while TNIP1 and autophagy receptors regulate STING turnover. PIAS1 SUMOylates and inhibits NF-κB subunits. Endocytic ESCRT components sort receptors for degradation, thereby reducing signaling.
Post-translational modification and degradation
In simple terms: Chemical tags mark signaling proteins for destruction or inactivation.
Ubiquitination, SUMOylation, and phosphorylation are common mechanisms. PIAS1-mediated SUMOylation of NF-κB suppresses its transcriptional activity. TAX1BP1 promotes ubiquitin-dependent degradation of STING. ESCRT-mediated sorting delivers receptors to lysosomes for degradation.
Signal attenuation and reset
In simple terms: The pathway is turned down so the cell can respond again later.
Once inhibitory complexes act, the signaling output declines. This reset is critical for avoiding chronic inflammation and for allowing cells to respond to subsequent stimuli. Defects in this step lead to persistent STING and NF-κB activation.
Cross-talk with developmental and metabolic pathways
In simple terms: Brakes on one pathway can affect others.
Negative regulators often intersect with developmental signaling. The endocytic pathway positively and negatively regulates developmental signals, and Smad inhibitors such as SMAD7 dampen TGF-β signaling. Gβγ subunits also modulate downstream cascades, and melanin pigmentation is controlled by hormonal regulation of intracellular signaling.
Key Genes Involved in GO:1902532 negative regulation of intracellular signal transduction
The following genes and proteins are representative negative regulators of intracellular signal transduction, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TAX1BP1 | Promotes Golgiphagy-mediated degradation of STING to terminate signaling | Target for studying STING-driven autoinflammation and cancer immunity |
| TNIP1 | Regulates STING signaling together with autophagy receptors | Candidate for autoimmune and inflammatory disease models |
| PIAS1 | SUMOylates and inhibits NF-κB signaling | Model for NF-κB-dependent inflammation and cancer |
| SMAD7 | Inhibitory Smad that blocks TGF-β/Smad signaling | Developmental and fibrosis research |
| ESCRT components | Sort receptors for degradation, attenuating signaling | Endocytic regulation of receptor tyrosine kinases |
| Gβγ subunits | Modulate downstream signaling in different cellular spaces | GPCR signaling specificity studies |
| STING1 | Innate immune adaptor whose activity is negatively regulated | Autoinflammatory and antiviral research |
| NFKB1 | Transcription factor inhibited by PIAS1 | Inflammation and immune regulation |
| ATG5 | Autophagy component involved in STING turnover | Autophagy-immune cross-talk |
| SQSTM1 | Autophagy receptor regulating STING | Selective autophagy research |
| SMAD2 | TGF-β effector negatively regulated by SMAD7 | Developmental signaling |
| SMAD3 | TGF-β effector negatively regulated by SMAD7 | Fibrosis and cancer models |
| TGFBR1 | Receptor whose signaling is attenuated by inhibitory Smads | Receptor trafficking studies |
| TGFBR2 | Receptor whose signaling is attenuated by inhibitory Smads | Receptor trafficking studies |
| VPS4 | ESCRT-associated ATPase involved in receptor sorting | Endosomal sorting research |
| TSG101 | ESCRT-I component mediating receptor degradation | Viral budding and receptor downregulation |
| CHMP4B | ESCRT-III component in membrane scission | Membrane remodeling studies |
How Is negative regulation of intracellular signal transduction Regulated?
Negative regulation of intracellular signal transduction is itself regulated at multiple levels. Transcription of inhibitory proteins such as PIAS1 and TNIP1 is induced by the same pathways they later suppress, creating negative feedback loops. Post-translational modifications, including phosphorylation and ubiquitination, control the stability and activity of these regulators. Endocytic trafficking determines whether receptors are recycled or degraded, thereby setting the duration of signaling. In addition, developmental cues and hormonal signals can tune the expression of negative regulators, as seen in melanin pigmentation and Gβγ-mediated modulation.
negative regulation of intracellular signal transduction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TAX1BP1 | STING-driven autoinflammation | Knockout cell line + STING agonist challenge |
| TNIP1 | Autoimmune and inflammatory disease | Knockout and overexpression models |
| PIAS1 | NF-κB-associated inflammation and cancer | Point-mutation and knockout models |
| SMAD7 | Fibrosis and developmental disorders | Knock-in reporter and knockout models |
| ESCRT components | Developmental and trafficking disorders | Knockout and tagged knock-in models |
Autoinflammatory and autoimmune disease
Loss of negative regulators such as TAX1BP1 or TNIP1 leads to sustained STING signaling, which can cause autoinflammatory disease. Similarly, impaired PIAS1 function may enhance NF-κB activity and promote chronic inflammation.
Cancer
Negative regulators of intracellular signal transduction can act as tumor suppressors or oncogenes depending on context. For example, PIAS1-mediated inhibition of NF-κB may limit tumor cell survival, while defective STING termination could alter anti-tumor immunity.
Developmental disorders
Proper negative regulation of TGF-β/Smad and endocytic signaling is required for normal development. Disruption of inhibitory Smads or ESCRT components can lead to developmental defects.
Pigmentation and hormonal disorders
Melanin pigmentation in mammalian skin is regulated by hormonal control of intracellular signaling, and its dysregulation can contribute to pigmentation disorders.
From negative regulation of intracellular signal transduction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is TAX1BP1 required for STING termination? | TAX1BP1 knockout cell line |
| Does TNIP1 regulate STING through autophagy? | TNIP1 knockout and ATG5 knockout models |
| Does PIAS1 SUMOylate NF-κB in vivo? | PIAS1 point-mutation knock-in |
| How does SMAD7 inhibit TGF-β signaling? | SMAD7 overexpression and knockout |
| Which ESCRT components control receptor degradation? | ESCRT subunit knockout library |
| Does Gβγ localization affect signaling output? | Tagged knock-in of Gβγ subunits |
How to Study the negative regulation of intracellular signal transduction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function effect on signaling | Identify required negative regulators |
| Point mutation knock-in | Specific residue function | Dissect SUMOylation or phosphorylation sites |
| RNA-seq | Transcriptional changes | Measure pathway output and feedback genes |
| Proteomics | Protein abundance and modifications | Detect ubiquitination or SUMOylation |
| Live-cell imaging | Protein localization and dynamics | Track receptor trafficking and degradation |
| CRISPR library screening | Genome-wide regulators | Discover novel negative regulators |
| Co-immunoprecipitation | Protein-protein interactions | Map inhibitory complexes |
| Autophagy flux assays | Autophagic degradation | Study STING turnover |
CRISPR knockout and point-mutation models
Knockout of candidate negative regulators such as TAX1BP1 or TNIP1 can reveal whether they are required to terminate STING signaling. Point mutations can dissect specific domains, such as the SUMOylation site in PIAS1.
Transcriptomics and proteomics
RNA-seq and proteomics can measure changes in signaling output and identify feedback-induced genes after knockout or overexpression of negative regulators.
Imaging and trafficking assays
Live-cell imaging of tagged receptors and ESCRT components can visualize how endocytic trafficking attenuates signaling.
CRISPR library screening
Genome-wide CRISPR screens can identify novel negative regulators of a given signaling pathway by selecting for cells with sustained pathway activity.
How CRISPR Can Be Used to Study GO:1902532 negative regulation of intracellular signal transduction
Knockout
CRISPR knockout of negative regulators such as TAX1BP1, TNIP1, or PIAS1 can cause sustained signaling and is a powerful way to test causality.
Point Mutation
Point mutations can be introduced to ablate specific post-translational modification sites, for example the SUMOylation site in PIAS1, to test its role in NF-κB inhibition.
Knock-in
Tagged knock-in of endogenous genes, such as GFP-tagged STING or ESCRT components, allows real-time visualization of negative regulation in live cells.
Overexpression
Overexpression of negative regulators like SMAD7 or TNIP1 can suppress signaling and is useful for gain-of-function studies.
How EDITGENE Supports negative regulation of intracellular signal transduction Research
Researchers studying negative regulation of intracellular signal transduction-related genes often need to determine whether a candidate gene is causally involved in stopping or reducing a signaling pathway. This requires precise genetic models that can knockout, mutate, tag, or overexpress the gene of interest in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of intracellular signal transduction research.
Frequently Asked Questions About negative regulation of intracellular signal transduction
What is GO:1902532?
GO:1902532 is the Gene Ontology term for negative regulation of intracellular signal transduction, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of intracellular signal transduction.
What genes are involved in negative regulation of intracellular signal transduction?
Key genes include TAX1BP1, TNIP1, PIAS1, SMAD7, ESCRT components, and Gβγ subunits, among others.
How does negative regulation of intracellular signal transduction work?
It works through negative feedback loops, inhibitory protein recruitment, post-translational modifications such as ubiquitination and SUMOylation, and endocytic degradation of signaling receptors.
Why is negative regulation of intracellular signal transduction important?
It prevents runaway inflammation, controls developmental signaling, and maintains cellular homeostasis; its dysregulation causes autoinflammatory disease and cancer.
What diseases are linked to defects in negative regulation of intracellular signal transduction?
Autoinflammatory diseases, autoimmune conditions, cancer, and developmental disorders have been linked to defective negative regulation.
How can I study negative regulation of intracellular signal transduction with CRISPR?
CRISPR knockout, point mutation, knock-in tagging, and overexpression models allow causal testing of candidate regulators in relevant cell types.
What is the role of TAX1BP1 in STING signaling?
TAX1BP1 promotes Golgiphagy-mediated degradation of STING to terminate signaling.
How does PIAS1 inhibit NF-κB?
PIAS1 SUMOylates NF-κB subunits and suppresses their transcriptional activity.
What is the role of ESCRT in signal transduction?
ESCRT components sort activated receptors for degradation, thereby attenuating signaling.
Can EDITGENE help me create knockout models for negative regulators?
Yes, EDITGENE provides knockout, point-mutation, knock-in, overexpression, and library screening services for genes involved in negative regulation of intracellular signal transduction.
Conclusion
Negative regulation of intracellular signal transduction (GO:1902532) is a fundamental biological process that protects cells from excessive signaling. Its mechanisms range from feedback inhibition to targeted degradation of signaling components, and its dysfunction is implicated in autoinflammation, cancer, and developmental disorders. CRISPR-based models are indispensable for dissecting these pathways, and EDITGENE offers comprehensive services to accelerate such research.
References
- 1. Suklabaidya S et al.. 2026. Negative feedback regulation of STING signaling by TAX1BP1-directed Golgiphagy.. Nat Commun 17(1) PMID: 41673009
- 2. Slominski A et al.. 2004. Melanin pigmentation in mammalian skin and its hormonal regulation.. Physiol Rev 84(4):1155-228 PMID: 15383650
- 3. Roxrud I et al.. 2010. ESCRT & Co.. Biol Cell 102(5):293-318 PMID: 20222872
- 4. Wrana JL et al.. 2000. The Smad pathway.. Cytokine Growth Factor Rev 11(1-2):5-13 PMID: 10708948
- 5. Bunker EN et al.. 2026. TNIP1 and autophagy receptors regulate STING signaling.. Mol Biol Cell 37(2):ar17 PMID: 41442157
- 6. Liu B et al.. 2005. Negative regulation of NF-kappaB signaling by PIAS1.. Mol Cell Biol 25(3):1113-23 PMID: 15657437
- 7. Khan SM et al.. 2016. Gβγ subunits-Different spaces, different faces.. Pharmacol Res 111:434-441 PMID: 27378564
- 8. Wada Y et al.. 2013. Positive and negative regulation of developmental signaling by the endocytic pathway.. Curr Opin Genet Dev 23(4):391-8 PMID: 23669551
